BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Seagen Inc.
Eli Lilly and Company
Pfizer
University of California, Irvine
Pfizer
Eli Lilly and Company
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
Shanghai Zhongshan Hospital
Blueprint Medicines Corporation
M.D. Anderson Cancer Center
Tesaro, Inc.
Eli Lilly and Company
Toray Industries, Inc
Washington University School of Medicine
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Adlai Nortye Biopharma Co., Ltd.
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
OHSU Knight Cancer Institute
University of Nebraska
Emory University
Canadian Cancer Trials Group
Fox Chase Cancer Center
Fox Chase Cancer Center
AstraZeneca
AIDS Malignancy Consortium
Gilead Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Celgene
M.D. Anderson Cancer Center
Celgene
AbbVie
Maastricht Radiation Oncology
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Stanford University
National Institutes of Health Clinical Center (CC)